Human adrenal corticocarcinoma NCI-H295R cells produce more androgens than NCI-H295A cells and differ in 3beta-hydroxysteroid dehydrogenase type 2 and 17,20 lyase activities.

The human adrenal cortex produces mineralocorticoids, glucocorticoids, and androgens in a species-specific, hormonally regulated, zone-specific, and developmentally characteristic fashion. Most molecular studies of adrenal steroidogenesis use human adrenocortical NCI-H295A and NCI-H295R cells as a model because appropriate animal models do not exist. NCI-H295A and NCI-H295R cells originate from the same adrenocortical carcinoma which produced predominantly androgens but also smaller amounts of mineralocorticoids and glucocorticoids. Research data obtained from either NCI-H295A or NCI-H295R cells are generally compared, although for the same experiments no direct comparison between the two cell lines has been performed. Therefore, we compared the steroid profile and the expression pattern of important genes involved in steroidogenesis in both cell lines. We found that steroidogenesis differs profoundly. NCI-H295A cells produce more mineralocorticoids, whereas NCI-H295R cells produce more androgens. Expression of the 3beta-hydroxysteroid dehydrogenase (HSD3B2), cytochrome b5, and sulfonyltransferase genes is higher in NCI-H295A cells, whereas expression of the cytochrome P450c17 (CYP17), 21-hydroxylase (CYP21), and P450 oxidoreductase genes does not differ between the cell lines. We found lower 3beta-hydroxysteroid dehydrogenase type 2 but higher 17,20-lyase activity in NCI-H295R cells explaining the 'androgenic' steroid profile for these cells and resembling the zona reticularis of the human adrenal cortex. Both cell lines were found to express the ACTH receptor at low levels consistent with low stimulation by ACTH. By contrast, both cell lines were readily stimulated by 8Br-cAMP. The angiotensin type 1 receptor was highly expressed in NCI-H295R than NCI-H295A cells and angiotensin II stimulated steroidogenesis in NCI-H295R but not NCI-H295A cells. Our data suggest that comparative studies between NCI-H295A and NCI-H295R cells may help find important regulators of mineralocorticoid or androgen biosynthesis.

[1]  R. Auchus,et al.  The rise in adrenal androgen biosynthesis: adrenarche. , 2004, Seminars in reproductive medicine.

[2]  G. Hodgen,et al.  Adrenarche: a survey of rodents, domestic animals, and primates. , 1978, Endocrinology.

[3]  H. Sasano,et al.  Adrenarche Results from Development of a 3β-Hydroxysteroid Dehydrogenase-Deficient Adrenal Reticularis , 1998 .

[4]  I. Bird,et al.  The role of cytochrome P450 17 alpha-hydroxylase and 3 beta-hydroxysteroid dehydrogenase in the integration of gonadal and adrenal steroidogenesis via the delta 5 and delta 4 pathways of steroidogenesis in mammals. , 1997, Biology of reproduction.

[5]  K. Choy,et al.  Mutation of proline 409 to arginine in the meander region of cytochrome p450c17 causes severe 17 alpha-hydroxylase deficiency. , 2001, Molecular genetics and metabolism.

[6]  M. Waterman,et al.  Insights into the Transcriptional Regulation of Steroidogenic Enzymes and StAR , 2001, Reviews in Endocrine and Metabolic Disorders.

[7]  W. Miller,et al.  Dexamethasone does not exert direct intracellular feedback on steroidogenesis in human adrenal NCI-H295A cells. , 2003, The Journal of endocrinology.

[8]  J. Mathis,et al.  Human NCI-H295 adrenocortical carcinoma cells: a model for angiotensin-II-responsive aldosterone secretion. , 1993, Endocrinology.

[9]  Matheus H. Dias,et al.  ACTH receptor: Ectopic expression, activity and signaling , 2006, Molecular and Cellular Biochemistry.

[10]  Takashi Suzuki,et al.  Temporal and spatial distribution of Corticosteroidogenic Enzymes Immunoreactivity in developing human adrenal , 2001, Molecular and Cellular Endocrinology.

[11]  N. Hanley,et al.  Regulation of human adrenal carcinoma cell (NCI-H295) production of C19 steroids. , 1993, The Journal of clinical endocrinology and metabolism.

[12]  S. Black,et al.  Steroid 17 alpha-hydroxylase and 17,20-lyase activities of P450c17: contributions of serine106 and P450 reductase. , 1993, Endocrinology.

[13]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[14]  Sevin.  [Adrenal glands]. , 1959, Produits pharmaceutiques.

[15]  John L Newsted,et al.  Human adrenocarcinoma (H295R) cells for rapid in vitro determination of effects on steroidogenesis: hormone production. , 2006, Toxicology and applied pharmacology.

[16]  B. Campbell.  Adrenarche and the evolution of human life history , 2006, American journal of human biology : the official journal of the Human Biology Council.

[17]  R. Cone,et al.  ACTH induces up-regulation of ACTH receptor mRNA in mouse and human adrenocortical cell lines , 1994, Molecular and Cellular Endocrinology.

[18]  M. Waterman,et al.  Signal transduction pathways combining peptide hormones and steroidogenesis. , 1996, Vitamins and hormones.

[19]  H. Sasano,et al.  Adrenarche is associated with decreased 3 beta-hydroxysteroid dehydrogenase expression in the adrenal reticularis. , 1996, Endocrine research.

[20]  B. Schimmer,et al.  Adrenocortical cell lines , 2004, Molecular and Cellular Endocrinology.

[21]  C. Flück,et al.  Pioglitazone Inhibits Androgen Production in NCI-H295R Cells by Regulating Gene Expression of CYP17 and HSD3B2 , 2007, Molecular Pharmacology.

[22]  D. Ehrmann,et al.  Detection of functional ovarian hyperandrogenism in women with androgen excess. , 1992, The New England journal of medicine.

[23]  I. Bird,et al.  Regulation of type 1 angiotensin II receptor messenger ribonucleic acid expression in human adrenocortical carcinoma H295 cells. , 1994, Endocrinology.

[24]  D. Hum,et al.  Transcription of the human genes for cytochrome P450scc and P450c17 is regulated differently in human adrenal NCI-H295 cells than in mouse adrenal Y1 cells. , 1997, The Journal of clinical endocrinology and metabolism.

[25]  M. Waterman,et al.  Transcriptional regulation of steroid hydroxylase genes by corticotropin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Fassnacht,et al.  Management of adrenocortical carcinoma , 2004, Clinical endocrinology.

[27]  D. Hum,et al.  Regulation of steroidogenesis in NCI-H295 cells: a cellular model of the human fetal adrenal. , 1993, Molecular endocrinology.

[28]  Y. Jo,et al.  Multiple signaling pathways regulating steroidogenesis and steroidogenic acute regulatory protein expression: more complicated than we thought. , 2005, Molecular endocrinology.

[29]  W. Miller,et al.  GATA-4 and GATA-6 modulate tissue-specific transcription of the human gene for P450c17 by direct interaction with Sp1. , 2004, Molecular endocrinology.

[30]  L. Hunyady,et al.  Failed export of the adrenocorticotrophin receptor from the endoplasmic reticulum in non-adrenal cells: evidence in support of a requirement for a specific adrenal accessory factor. , 2002, The Journal of endocrinology.

[31]  I. Bird,et al.  The NCI-H295 cell line: a pluripotent model for human adrenocortical studies , 1994, Molecular and Cellular Endocrinology.

[32]  Joseph Sack,et al.  Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis. , 2005, American journal of human genetics.

[33]  T. Triche,et al.  Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis. , 1990, Cancer research.

[34]  K. Clément,et al.  Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. , 2000, The Journal of clinical investigation.

[35]  D. Brann,et al.  Interaction between ovarian and adrenal steroids in the regulation of gonadotropin secretion , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[36]  W. Miller,et al.  Protein Phosphatase 2A and Phosphoprotein SET Regulate Androgen Production by P450c17* , 2003, The Journal of Biological Chemistry.

[37]  W L Miller,et al.  Molecular biology of steroid hormone synthesis. , 1988, Endocrine reviews.

[38]  K. O. Elliston,et al.  Male pseudohermaphroditism caused by mutations of testicular 17β–hydroxysteroid dehydrogenase 3 , 1994, Nature Genetics.

[39]  Takashi Suzuki,et al.  Dissecting human adrenal androgen production , 2002, Trends in Endocrinology & Metabolism.

[40]  W. Miller,et al.  The regulation of 17,20 lyase activity , 1997, Steroids.

[41]  W. Miller.  Disorders of Androgen Biosynthesis , 2002, Seminars in reproductive medicine.

[42]  S. Bornstein,et al.  Local renin-angiotensin system is involved in K+-induced aldosterone secretion from human adrenocortical NCI-H295 cells. , 1999, Hypertension.

[43]  M. Waterman,et al.  Regulation of cholesterol side-chain cleavage cytochrome P-450 gene expression in adrenal cells in monolayer culture , 1986, Molecular and Cellular Endocrinology.

[44]  R. Danesi,et al.  Clinical and experimental evidence of inhibition of testosterone production by suramin. , 1996, The Journal of clinical endocrinology and metabolism.

[45]  W. Miller,et al.  Effects of Anticonvulsants on Human P450c17 (17α‐Hydroxylase/17,20 Lyase) and 3β‐Hydroxysteroid Dehydrogenase Type 2 , 2005 .

[46]  W. Miller,et al.  Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[47]  S. Andò,et al.  Role of Calmodulin-dependent protein kinase II in the acute stimulation of aldosterone production , 1996, The Journal of Steroid Biochemistry and Molecular Biology.

[48]  P. Soucy,et al.  Characteristics of a Highly Labile Human Type 5 17β-Hydroxysteroid Dehydrogenase1. , 1999, Endocrinology.

[49]  D. Langdon.  Adrenarche Results from Development of a 3b-Hydroxysteroid Dehydrogenase-Deficient Adrenal Reticularis , 1999 .

[50]  W. Miller,et al.  Regulation of 17,20 Lyase Activity by Cytochrome b5 and by Serine Phosphorylation of P450c17* , 2005, Journal of Biological Chemistry.

[51]  W. Freije,et al.  Developmental changes in steroidogenic enzymes in human postnatal adrenal cortex: immunohistochemical studies , 2000, Clinical endocrinology.

[52]  David I. Wilson,et al.  In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development. , 2006, The Journal of clinical investigation.

[53]  G. Dhom,et al.  The prepuberal and puberal growth of the adrenal (adrenarche). , 1973, Beitrage zur Pathologie.

[54]  J. Martens,et al.  NF-1C, Sp1, and Sp3 are essential for transcription of the human gene for P450c17 (steroid 17alpha-hydroxylase/17,20 lyase) in human adrenal NCI-H295A cells. , 2001, Molecular endocrinology.

[55]  M. Waterman,et al.  cAMP-dependent Protein Kinase Enhances CYP17 Transcription via MKP-1 Activation in H295R Human Adrenocortical Cells* , 2003, The Journal of Biological Chemistry.

[56]  M. Waterman,et al.  cAMP-dependent transcription of steroidogenic genes in the human adrenal cortex requires a dual-specificity phosphatase in addition to protein kinase A. , 2002, Journal of molecular endocrinology.

[57]  W. Miller,et al.  Cytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer* , 1998, The Journal of Biological Chemistry.

[58]  R. Legro,et al.  Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. , 1999, Molecular endocrinology.

[59]  D. Ehrmann,et al.  Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. , 1989, The New England journal of medicine.

[60]  J. L. San Millán,et al.  The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. , 2005, Endocrine reviews.